Aspiration Pneumonia with Severity Criteria and Previous Documented MRSA Colonization

This protocol addresses patients with aspiration pneumonia meeting severity criteria who have a prior documented colonization with methicillin-resistant Staphylococcus aureus (MRSA). That history is a critical risk factor that directly shapes the empirical antibiotic approach.

Clinical Scenario

Pneumonia with severity criteria, plus a history of documented colonization with methicillin-resistant Staphylococcus aureus (MRSA). Prior MRSA colonization is a recognized risk factor for MRSA infection in severe pneumonia and must be accounted for in empirical antibiotic selection.

Treatment Approach

In this scenario, the empirical antibiotic regimen is expanded with an additional agent providing targeted MRSA-active coverage — the specific agent, full selection criteria, and sequencing are detailed in the complete protocol.

Clinical Goals — 72-Hour Assessment

Response is evaluated at 72 hours. A positive clinical course requires all of the following stability criteria to be met:

Temperature ≤ 37.8 °C
Systolic blood pressure ≥ 90 mm Hg
Heart rate ≤ 100/min
Respiratory rate ≤ 24/min
SpO&sub2; ≥ 90% or PaO&sub2; ≥ 60 mm Hg in ambient air

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.idnow.2025.105081

It is recommended to consider risk factors for infection that could involve Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) (Grade B-1).
Adding linezolid is recommended in the empirical treatment of patients with previous documented colonization with MRSA (Grade B-1).
The positive clinical course is evaluated at 72 h by the presence of all of the following clinical stability criteria: Temperature ≤ 37.8 °C; Systolic blood pressure ≥ 90 mm Hg; Heart rate ≤ 100/min; Respiratory rate ≤ 24/min; SpO2 ≥ 90% or PaO2 ≥ 60 mm Hg in ambient air.

View source ↗